Inhibitory Activity on DNA Gyrase and Intracellular Accumulation of Quinolones : Structure-Activity Relationship of Q-35 Analogs
スポンサーリンク
概要
- 論文の詳細を見る
Q-35,1-cyclopropy-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylaminopiperidine-1-yl)-4-oxoquinoline-3-car-boxylic acid, has excellent activity against gram-positive bacteria and inhibits S. aureus gyrase at concentrations more than 10-fold lower than those of other quinolones. In this paper, the effect of the C-7 and C-8 substituents of Q-35 on the inhibitory activity of gyrase purifled from S. aureus, M. luteus, E. coli, and P. aeruginosa are described. In addition, intracellular accumulation of Q-35 was examined. The 50% inhibitory concentrations (IC_<50>) of Q-35,8-fluoro-Q-35,and 8-hydro-Q-35 on DNA gyrase purified from S. aureus were 2.5,7.8,and 68μg/ml, respectively. The IC_<50> on gyrase from P. aeruginosa were 11,5.2,and 17 μg/ml, respectively. It is concluded that the introduction of a methoxy group into the 8 position of the quinolone leads to greater antibacterial activity against gram-positive bacteria. The concentrations of Q-35 which accumulated in S. aureus and E. coli were almost equal to ciprofloxacin, but in P. aeruginosa, Q-35 was lower than ciprofloxacin.
- 社団法人日本薬学会の論文
- 1994-07-15
著者
-
西野 武志
Department Of Microbiology Kyoto Pharmaceutical University.
-
伊藤 達也
Department of Microbiology, Kyoto Pharmaceutical University. Fuji-Gotenbga Research Laboratories, Ch
-
小嶋 佳奈
Fuji-Gotenbga Research Laboratories, Chugai Pharmaceutical Co., Ltd.
-
小泉 〓也
Fuji-Gotenbga Research Laboratories, Chugai Pharmaceutical Co., Ltd.
-
永野 洋幸
Fuji-Gotenbga Research Laboratories, Chugai Pharmaceutical Co., Ltd.
-
伊藤 達也
京都薬科大学微生物学教室
-
小嶋 佳奈
中外製薬株式会社富士御殿場研究所
-
永野 洋幸
中外製薬株式会社富士御殿場研究所
-
小泉 〓也
Fuji-gotenbga Research Laboratories Chugai Pharmaceutical Co. Ltd.
-
伊藤 達也
Department Of Civil Engineering Faculty Of Engineering Gifuuniversity
-
永野 洋幸
中外製薬 富士御殿場研
関連論文
- Inhibitory Activity on DNA Gyrase and Intracellular Accumulation of Quinolones : Structure-Activity Relationship of Q-35 Analogs
- 都市高速道路乗り継ぎ制の理論モデル
- Balofloxacinのin vitroおよびin vivo抗菌力
- 5.肝における 1α-Hydroxyvitamin D_3の 1α, 25-Dihydroxyvitamin D_3への代謝(脂溶性ビタミン総合研究委員会 : 第156回会議研究発表要旨)
- 新キノロン系抗菌薬balofloxacinのin vivo抗菌作用
- 新キノロン系抗菌薬balofloxacinのin vitro抗菌作用